Latest Articles

Publication Date
Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy - Targeted Oncology

Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy Targeted Oncology

Published: Jan. 5, 2026, 1:07 p.m.
Does menopause increase endometrial cancer risk? | Tap to know more | Inshorts - Inshorts

Does menopause increase endometrial cancer risk? | Tap to know more | Inshorts Inshorts

Published: Jan. 4, 2026, 7:43 a.m.
FBXW7 Identified as Key Regulator of M2 Macrophage Polarization in Endometrial Cancer - geneonline.com

FBXW7 Identified as Key Regulator of M2 Macrophage Polarization in Endometrial Cancer geneonline.com

Published: Jan. 4, 2026, 6:37 a.m.
FBXW7 Modulates M2 Macrophage Polarization in Endometrial Cancer - Bioengineer.org

FBXW7 Modulates M2 Macrophage Polarization in Endometrial Cancer Bioengineer.org

Published: Jan. 4, 2026, 5:52 a.m.
FBXW7 Modulates M2 Macrophage Polarization in Endometrial Cancer - BIOENGINEER.ORG

FBXW7 Modulates M2 Macrophage Polarization in Endometrial Cancer BIOENGINEER.ORG

Published: Jan. 4, 2026, 5:52 a.m.
Kristina Lindemann: The Prognostic Value of Preoperative ctDNA Assessment in Endometrial Cancer - Oncodaily

Kristina Lindemann: The Prognostic Value of Preoperative ctDNA Assessment in Endometrial Cancer Oncodaily

Published: Jan. 3, 2026, 8:59 p.m.
Endometrial Cancer: Sequencing Lenvatinib–Pembrolizumab - Alignment with Trials, Post-Adjuvant Potential, and Dose Flexibility - OncLive

Endometrial Cancer: Sequencing Lenvatinib–Pembrolizumab - Alignment with Trials, Post-Adjuvant Potential, and Dose Flexibility OncLive

Published: Jan. 2, 2026, 1:12 p.m.
Endometrial Cancer: Framing Prognosis, Weaving Clinical Trials and Real-World Data into Patient Conversations - OncLive

Endometrial Cancer: Framing Prognosis, Weaving Clinical Trials and Real-World Data into Patient Conversations OncLive

Published: Jan. 2, 2026, 1:10 p.m.
Beyond VEGF and TGF-β: A Comprehensive Review of Growth Factor Pathways in the Pathophysiology of Uterine Leiomyomas.

Uterine leiomyomas or fibroids, are non-cancerous smooth muscle proliferations of the uterus, occurring mostly in women of reproductive age. Their pathogenesis involves complex growth factor interactions that regulate cellular proliferation, …

Published: Jan. 1, 2026, midnight
Expanded Histologic Lineage and Origin of Mesonephric-Like Adenocarcinoma: A Clinicopathologic Study of 9 Cases.

Mesonephric-like adenocarcinoma (MLA) is a rare gynecologic malignancy primarily arising in the uterine corpus and ovaries. It shares remarkable similarities in its histomorphology, immunophenotype, and molecular features with mesonephric adenocarcinoma …

Published: Dec. 31, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!